Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Filgrastim

    ... It is known as a hematopoietic growth factor or colony stimulating factorand is given by injection under the skin ...

    Drug last updated 03/24/2016 - 12:32pm.

  2. Immunosuppressive Therapy

    ... in about 7 out of 10 cases. When a platelet growth factor called eltrombopag (Promacta®) is also given, more than 7 in 10 ...

    Topic section last updated 04/01/2016 - 2:24pm.

  3. BMT - Bone Marrow v Stem Cell Transplantation

    ... stem cells (PBSC) – The donor is given a white cell  growth factor  that increases the production of white blood cells and also dislodges ...

    Page last updated 02/23/2016 - 1:05pm.

  4. BMT - Bone Marrow v Stem Cell

    ... stem cells (PBSC) – The donor is given a white cell  growth factor  that increases the production of white blood cells and also dislodges ...

    Topic section last updated 02/23/2016 - 12:59pm.

  5. Moderate, Severe, and Very Severe Aplastic Anemia: How are treatment decisions made?

    Are treatments for each category aplastic anemia (moderate, severe, and very severe) also category-specific or are they decided more on a case-by-case basis? That’s correct—an aplastic anemia diagnosis ...

    Interview last updated 10/14/2015 - 12:47pm.

  6. Eltrombopag: Recent Discoveries on Potential New Applications for Aplastic Anemia

    ... failure syndromes and the use of eltrombopag, a blood growth factor to treat aplastic anemia. She receives research funding support from ...

    Interview last updated 02/14/2014 - 2:01pm.

  7. Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.

    ... bone marrow myeloblasts and ANC > or = to 0.2 ( growth factor supported if necessary) at transplant work-up. Chronic ...

    Clinical Trial last updated 04/29/2016 - 3:51pm.

  8. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... makes the donor unlikely to tolerate or cooperate with growth factor therapy and leukapheresis. Factors which place the donor at ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.

  9. Immunosuppression and Stem Cell Transplantation – How Are These Treatments Chosen?

    ... in stimulating blood cell production. Eltrombopag is a growth factor , which was originally developed to treat immune thrombocytopenic ...

    Interview last updated 07/15/2015 - 10:19am.

  10. FAQs

    ... include blood transfusions and antibiotics, and may include growth factors or iron chelation for some patients. Immunosuppressive ... bone marrow to produce more blood cells. Red cell growth factor is most commonly used in bone marrow failure patients. It is called ...

    Topic section last updated 03/02/2016 - 11:42am.